- Home
- / Poolbeg Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Poolbeg Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0.1
2024-10-28
Market Capitalization
£40.5 M
2024-10-28
CreditSafe Score
?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Gross profit | 109.0K | 278.0K | 367.0K | 530.0K | 422.0K |
| Operating expense total | 2.4M | 5.2M | 5.0M | 6.5M | 6.4M |
| Depreciation and amortization | 18.0K | 26.0K | 379.0K | 114.0K | 85.0K |
| EBITDA | (2.3M) | (4.9M) | (4.7M) | (6.0M) | (5.9M) |
| EBIT | (2.3M) | (5.0M) | (5.0M) | (6.3M) | (6.0M) |
| Interest income | 428.0K | 253.0K | |||
| Pre tax profit | (2.3M) | (4.8M) | (4.5M) | (5.9M) | (5.8M) |
| Income tax expense | (91.0K) | (574.0K) | (154.0K) | (79.0K) | |
| Net Income | (2.3M) | (4.7M) | (3.9M) | (5.8M) | (5.7M) |